Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H (HK:6990) has released an update.
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. has officially announced the composition of its Board of Directors, including Chairman Mr. LIU Gexin and a mix of executive, non-executive, and independent directors. The company, which is incorporated in China and listed under stock code 6990, also outlined the membership of its three key Board committees: Audit, Remuneration, and Nomination, each chaired by respective experts in the field.
For further insights into HK:6990 stock, check out TipRanks’ Stock Analysis page.